Purification of a phosphate carrier in pig heart mitochondria by affinity chromatography on mersalyl—ultrogel  by Touraille, Sylvie et al.
Volume 128, number 1 FEBS LETTERS June 1981 
PURIFICATION OF A PHOSPHATE CARRIER IN PIG HEART MITOCHONDRIA BY 
AFFINITY CHROMATOGRAPHY ON MERSALYL-ULTROGEL 
Sylvie TOURAILLE, Yves BRIAND, Roger DURAND*, Jean-Claude BONNAFOUS+ and Jean-Claude MANI+ 
Laboratoire de Biochimie, ERA 692, Universite de Clermont II, B.P 45, 6317OAubiere and +Laboratoire de Biochimie des 
Membranes, ERA 228, 8, rue de I’Ecole Normale, 34075 Montpellier, France 
Received 15 April 1981 
1. Introduction 
Mersalyl is a powerful inhibitor of phosphate 
transport in mitochondria. In addition, by its revers- 
ible reaction with thiol groups, it can protect the 
latter from irreversible reaction with N-ethyl- 
maleimide [ 1,2]. Use of this property enabled a group 
of proteins of M, 3.0-3.2 X lo4 to be identified in 
the internal mitochondrial membrane [3-g]. This 
group of proteins could be directly labeled using 
radioactive mersalyl [6,9]. It was subsequently shown 
that these proteins consisted of a mersalyl and 
N-ethyhpaleimide-sensitive protein (M, 3.2 X 104) 
and the nucleotide translocase (M, 3.0 X IO”) 
[ IO,1 I]. These two proteins can be purified on 
hydroxyapatite [ 11 ,121. The mixture of the two pro- 
teins when integrated into liposomes catalyzes a 
Pi-Pi exchange which is sensitive to thiol-group 
reagents [ 121. 
This work describes the complete separation of the 
mersalyl and N-ethylmaleimide-sensitive protein from 
the nucleotide translocase. This purification was car- 
ried out by combining fractionation on a mersalyl- 
ultrogel column with purification on hydroxylapatite. 
2. Materials and methods 
Pig heart mitochondria were isolated according to 
[ 131 substituting 10 mM Tris-HCl buffer for the 
Abbreviations: EGTA, ethylencglycol tetraacetic acid; 
HEPES, N-2-hydroxyethylpipcrazine-N’-2, cthanc sulfonic 
acid; NEM, N-ethylmaleimide; Pi, inorganic phosphate; Tris, 
Tris (hydroxymethyl) amino methane 
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10 mM phosphate buffer. Proteins were assayed by 
the biuret method [ 141. Mitochondria were fraction- 
ated as in [ 151. SDS gel electrophoresis was done as 
in [16]. 
3. Results 
3.1. Preparation of rnersaly-ultrogel (I 7J 
The matrix derived from AM ultrogel A-4-R (reac- 
tifs IBF, Pharmindustrie), a 4% crosslinked agarose, 
by successive reactions with epichlorhydrine and 
ammonia:agarose-O-CH2-CH(OH)-CH2_NH2. 
Mersalyl (sodium o-((3-(hydroxymercuri)-2-meth- 
oxypropyl)-carbonyl)-phenoxyacetate) was coupled 
to the matrix by Boschetti’s method [ 181, using 
EEDQ (N-ethoxycarbonyl-2-ethoxy-I ,2-dihydroquin- 
oline) as a coupling agent. Gel (25 ml) was equili- 
brated in a water-ethanol (50:50) mixture. Mersalyl 
(0.06 M) in water-ethanol (5O:SO) was obtained by 
dissolving mersalyl acid (Sigma) in diluted NaOH, 
adjusting the pH to 7.5 and adding an equal volume 
of ethanol. This solution (max. 10 ml) was quickly 
added to EEDQ dissolved in the minimal volume of 
ethanol, under vigorous stirring. The mixture was 
then added to the gel. After gentle agitation for 16 h, 
mersalyl-ultrogel was successively washed with 
ethanol-water (50:50), 1 M NaCl and distilled water. 
The affinity gel used in this work contained 24 nmol 
mersalyl/ml. 
3.2. Purification of the mersalyl and N-ethylmaleim- 
i&-sensitive protein 
If the mixture of proteins from the internal mito- 
chondrial membrane is run through a mersalyl- 
ultrogel column, practically all the proteins with -SH 
groups would be expected to be retained. Retention 
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of the nucleotide translocase may be avoided by the 
following preliminary treatment on whole mitochon- 
dria: the mitochondrial phosphate carrier is first pro- 
tected with mersalyl, and then the -SH groups of the 
nucleotide translocase are irreversibly blocked with 
N-ethylmaleimide in the presence of ADP [ 19-211. 
Under these conditions the latter protein would not 
be expected to be retained on the mersalyl-ultrogel 
column. 
The subparticulate proteins are then prepared 
from mitochondria and dissolved in the presence of 
Triton. The solution is fractionated on a mersalyl- 
ultrogel column, and the retained proteins are eluted 
with dithiothreitol. Further purification of the eluted 
fraction on hydroxylapatite then yields the com- 
pletely pure phosphate carrier. 
3.2.1. Protection of phosphate carrier and fixation of 
N-ethylmaleimide on translocase 
Mitochondria (80 mg protein) were treated with 
20 nmol mersalyl/mg protein. The suspension of 
mitochondria was then treated with 1 mM NEM for 
2 min in the presence of 80 ,uM ADP. The reaction 
was stopped and the mersalyl removed by addition of 
cysteine. The mitochondria were found to still be 
able to catalyze phosphate transport as measured by 
swelling. 
3.2.2. Preparation of subparticulate proteins and frac- 
tionation on the mersalyl-ultrogel column 
Subparticulate proteins were prepared as in [6,1 I]. 
The proteins were dissolved in 6% Triton in 0.1 M 
NaCl (10 min, 4°C). Proteins (4-6 mg) were run 
through a 0.5 X 5 mersalyl-ultrogel column pre- 
treated with a 0.15 M NaCl, 1% Triton, 10 mM phos- 
phate buffer (pH 7.2). Flow rate was very low 
(1 drop/min). After washing out unretained proteins 
with the same buffer, retained proteins were eluted 
with 30 mM dithiothreitol. Mersalyl-ultrogel may be 
regenerated by washing the column with 10 mM 
HgClz and 20 mM EDTA in 50 mM sodium acetate at 
pH 4.8. Excess HgC12 is removed with 0.15 M NaCl in 
10 mM sodium phosphate (pH 7.2). 
3.2.3. Purification of the mersalyl- and N-ethyl- 
maleimide-sensitive protein 
The protein fraction eluted with dithiothreitol was 
treated with hydroxylapatite (0.5 g/ml fraction), then 
centrifuged (10 min at 27 000 X g). The pure protein 
was left in the supernatant linliid. 
Fig.1. Densitometric peaks of electrophoresis of the differ- 
ent protein fractions: (A) subparticular proteins; (fi) proteins 
obtained after fractionation on hydroxyapatite column; (C) 
proteins retained by the mersalyl-ultrogel column; (D) pro- 
tein ofMr 3.2 x lo4 obtained after fractionation on the 
mersalyl-ultrogel column and the fractionation on hydroxy- 
apatite. 
3.2.4. Electrophoresis of the different protein 
fractions 
Densitometric peaks of electrophoresis of protein 
fractions at the different stages of purification are 
shown in fig.1 ; (A) shows the protein bands of the 
subparticulate fraction. It is possible to clearly distin- 
guish between the phosphate carrier and the nucleo- 
tide translocase [ 111. The 2 proteins can be purified 
on a hydroxylapatite column (B). Photographs of 
both types of electrophoresis have been published 
[ 111. These results enable the relative proportions 
of phosphate carrier and nucleotide translocase to be 
estimated (20-25% and 75-80%, respectively). (C) 
shows the profile of the proteins retained on the 
mersalyl-ultrogel column. About 18 protein bands 
may be distinguished. The protein of Mr 3.2 X lo4 
can be seen to present in almost the same propor- 
tion as in the initial subparticulate fraction (A). At 
Mr 3.0 X 104, a protein band is present which could 
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Mr =3.2x10* 
Mr Z3.0 x10’ 
*Pi. :arrier 
c c+e D 
Fig.2. Electrophoresis of: (C) proteins retained by the mer- 
salyllultrogel column; (C + B) proteins resulting from the 
mixture of (C) plus purified proteins on hydroxyapatite col- 
umn (B); (D) protein of Mr 3.2 X lo4 obtained after frac- 
tionation on the mersalyl~ultrogel column and the fractiona- 
tion on hydroxyapatite. 
correspond either to residual unblocked nucleotide 
translocase, or to some other protein with the same 
molecular mass. The second explanation is apparently 
the correct one since subsequent purification on 
hydroxylapatite yielded only the phosphate carrier(D). 
An experiment using an internal standard was car- 
ried out to further check that the protein eluted from 
the mersalyl-ultrogel column was indeed the phos- 
phate carrier. The fraction eluted with dithiothreitol 
was combined with the mixture of the 2 proteins 
purified on hydroxyapatite as internal standard. Elec- 
trophoresis (fig.2 (B + C)) shows a strong increase in 
the intensity of both the nucleotide translocase band 
(M, 3.0 X 104) and the phosphate carrier band 
(M, 3.2 X 104). 
4. Conclusions 
Protection by mersalyl against NEM completely 
protects active phosphate transport [ 111. This protec- 
tion enabled a M, 3.2 X lo4 protein to be located, 
which could be prepared on hydroxylapatite along 
with a nucleotide translocase [ 111. Phosphate trans- 
port could be reconstituted by integrating the mix- 
ture of the 2 proteins into liposomes [ 121. 
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This paper describes a complete purification of the 
phosphate carrier by successive fractionation of sub- 
particulate proteins on an affinity column prepared 
with mersalyl-ultrogel and on hydroxyapatite. Recon- 
stitution of the mitochondrial phosphate transport 
system with the pure protein is being investigated. 
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